Objective To identify the most significantly compressed areas and the areas with the best recovery effects by analyzing the changes in vertebral height after percutaneous vertebroplasty(PVP)in patients with osteoporotic vertebral compression fractures(OVCF)through lateral radiographs.Methods A retrospective analysis was conducted on the lateral X-rays of 186 injured vertebrae from 142 patients hospitalized in our hospital's intervertebral disc center.The sagittal height of the vertebrae was measured at five different points before and after surgery,and the collected data were statistically analyzed using SPSS software.Results There were statistically significant differences in the heights of the five measured points before and after surgery within OVCF injured vertebrae(P＜0.05),in the ascending order:central＜mid-anterior＜mid-posterior＜anterior edge＜posterior edge.Comparison of the height parameters of the five measured points before and after surgery showed statistically significant differences(P＜0.01).In comparing the height restoration differences of the five measured points after PVP,the differences between central and mid-anterior,central and anterior edge,and mid-posterior and anterior edge were found not to be statistically significant(P＞0.05).The differences in height restoration for the remaining groups were statistically significant(P＜0.05),with the height restoration differences from highest to lowest being:mid-anterior,central,anterior edge,mid-posterior,posterior edge.Conclusion In patients with OVCF,the compression of the injured vertebra is most pronounced in the central part,followed by the mid-anterior part.PVP surgery can effectively restore the height of various parts of the injured vertebra,especially in the mid-anterior and central parts of the vertebral body,where the recovery effect is particularly significant.

Cartilage tissue engineering offers a novel therapeutic approach for auricular, tracheal, and joint reconstruction. Nevertheless, once implanted into the body, tissue-engineered cartilage is confronted with host immune rejection and inflammatory responses. These responses can result in cartilage deformation and fibrosis, thereby affecting the long-term maintenance of its morphology and function. Effectively modulating immune and inflammatory responses is crucial for advancing the clinical application of engineered cartilage. This article reviewed relevant literature to analyze the mechanisms of inflammatory responses occurring after the implantation of tissue-engineered cartilage, and summarized the types and surface characteristics of biomaterials, providing a reference for the design of biomaterials in cartilage tissue engineering.

The complement component 4 binding protein alpha(C4BPA)gene is the alpha chain of complement binding protein 4.As a plasma protein involved in the complement and coagulation systems,it can influence immune responses and lipid metabolism.In order to study the polymor-phism of C4BPA gene and its correlation with milk quality traits in Chinese Holstein cows,genom-ic DNA was extracted from blood samples of 92 Chinese Holstein cows,and the target fragment of C4BPA gene was amplified by PCR,and the association analysis was performed by using direct se-quencing to obtain the SNP loci and milk quality traits.The results showed that among the four SNPs found at the third intron of the C4BPA gene,I3-11 G＞A was highly significantly correlated with milk protein and urea nitrogen(P＜0.05),I3-291 T＞G was significantly correlated with lac-tose(P＜0.05),I3-374 C＞T was highly significantly correlated with lactose and urea nitrogen(P＜0.05),and I3-375 T＞G was highly significantly correlated with lactose(P＜0.05),milk pro-tein and urea nitrogen.The chi-square test values for each point indicated that the population was in genetic equilibrium.Individuals of haplotype combination H1 H1 had the highest lactose content,and haplotype combination H1H2 can be used as the best haplotype combination in the molecular selection work of dairy cows.

Objective:To investigate the expression level of miR-24-3p in peripheral blood of patients with type 2 diabetic nephropathy (DN) and its clinical significance.Methods:A cross-sectional study was conducted among 100 patients with simple type 2 diabetes mellitus (T2DM group) and 103 patients with DN (DN group). The relative expression level of miR-24-3p in the peripheral blood of patients in both groups was measured. Differences in miR-24-3p expression level among patients with DN were analyzed. The efficacy of miR-24-3p expression level in predicting the occurrence of DN was assessed.Results:The relative expression level of miR-24-3p in the peripheral blood of patients with DN was significantly higher than that of patients with T2DM [(1.43 ± 0.43) vs. (1.07 ± 0.33), t = -6.82, P < 0.05]. Significant differences in miR-24-3p level were observed among DN patients with varying levels of fasting blood glucose, glycated hemoglobin A1c, estimated glomerular filtration rate, and serum creatinine and magnesium levels ( t = -2.92, -2.90, -3.84, -3.41, -4.17, all P < 0.05). There was a statistically significant difference in miR-24-3p level among DN patients with different degrees of renal interstitial inflammation and renal interstitial fibrosis and tubular atrophy scores ( F = 48.73, 27.07, both P < 0.05). Correlation analysis revealed that the relative expression level of miR-24-3p in the peripheral blood of patients with DN was positively correlated with fasting blood glucose, glycated hemoglobin A1c, serum creatinine, renal interstitial inflammation score, and renal interstitial fibrosis and tubular atrophy score ( r = 0.48, 0.57, 0.63, 0.71, 0.69, all P < 0.05). It was negatively correlated with estimated glomerular filtration rate and blood magnesium level ( r = -0.72, -0.78, both P < 0.05). The relative expression level of miR-24-3p in the peripheral blood can be used to predict the occurrence of DN [area under the curve = 0.864, 95% CI: (0.813, 0.916)], and the sensitivity and specificity of this prediction were 85.0% and 79.6%, respectively. Conclusions:The expression of miR-24-3p is high in the peripheral blood of patients with DN, and its level is associated with blood glucose metabolism, blood magnesium level, renal inflammatory injury, renal interstitial fibrosis, and glomerular atrophy. Upregulation of miR-24-3p may increase the risk of renal disease and exacerbate kidney damage in patients with T2DM.

Objective To identify the most significantly compressed areas and the areas with the best recovery effects by analyzing the changes in vertebral height after percutaneous vertebroplasty(PVP)in patients with osteoporotic vertebral compression fractures(OVCF)through lateral radiographs.Methods A retrospective analysis was conducted on the lateral X-rays of 186 injured vertebrae from 142 patients hospitalized in our hospital's intervertebral disc center.The sagittal height of the vertebrae was measured at five different points before and after surgery,and the collected data were statistically analyzed using SPSS software.Results There were statistically significant differences in the heights of the five measured points before and after surgery within OVCF injured vertebrae(P＜0.05),in the ascending order:central＜mid-anterior＜mid-posterior＜anterior edge＜posterior edge.Comparison of the height parameters of the five measured points before and after surgery showed statistically significant differences(P＜0.01).In comparing the height restoration differences of the five measured points after PVP,the differences between central and mid-anterior,central and anterior edge,and mid-posterior and anterior edge were found not to be statistically significant(P＞0.05).The differences in height restoration for the remaining groups were statistically significant(P＜0.05),with the height restoration differences from highest to lowest being:mid-anterior,central,anterior edge,mid-posterior,posterior edge.Conclusion In patients with OVCF,the compression of the injured vertebra is most pronounced in the central part,followed by the mid-anterior part.PVP surgery can effectively restore the height of various parts of the injured vertebra,especially in the mid-anterior and central parts of the vertebral body,where the recovery effect is particularly significant.

The complement component 4 binding protein alpha(C4BPA)gene is the alpha chain of complement binding protein 4.As a plasma protein involved in the complement and coagulation systems,it can influence immune responses and lipid metabolism.In order to study the polymor-phism of C4BPA gene and its correlation with milk quality traits in Chinese Holstein cows,genom-ic DNA was extracted from blood samples of 92 Chinese Holstein cows,and the target fragment of C4BPA gene was amplified by PCR,and the association analysis was performed by using direct se-quencing to obtain the SNP loci and milk quality traits.The results showed that among the four SNPs found at the third intron of the C4BPA gene,I3-11 G＞A was highly significantly correlated with milk protein and urea nitrogen(P＜0.05),I3-291 T＞G was significantly correlated with lac-tose(P＜0.05),I3-374 C＞T was highly significantly correlated with lactose and urea nitrogen(P＜0.05),and I3-375 T＞G was highly significantly correlated with lactose(P＜0.05),milk pro-tein and urea nitrogen.The chi-square test values for each point indicated that the population was in genetic equilibrium.Individuals of haplotype combination H1 H1 had the highest lactose content,and haplotype combination H1H2 can be used as the best haplotype combination in the molecular selection work of dairy cows.

Objective:To investigate the expression level of miR-24-3p in peripheral blood of patients with type 2 diabetic nephropathy (DN) and its clinical significance.Methods:A cross-sectional study was conducted among 100 patients with simple type 2 diabetes mellitus (T2DM group) and 103 patients with DN (DN group). The relative expression level of miR-24-3p in the peripheral blood of patients in both groups was measured. Differences in miR-24-3p expression level among patients with DN were analyzed. The efficacy of miR-24-3p expression level in predicting the occurrence of DN was assessed.Results:The relative expression level of miR-24-3p in the peripheral blood of patients with DN was significantly higher than that of patients with T2DM [(1.43 ± 0.43) vs. (1.07 ± 0.33), t = -6.82, P < 0.05]. Significant differences in miR-24-3p level were observed among DN patients with varying levels of fasting blood glucose, glycated hemoglobin A1c, estimated glomerular filtration rate, and serum creatinine and magnesium levels ( t = -2.92, -2.90, -3.84, -3.41, -4.17, all P < 0.05). There was a statistically significant difference in miR-24-3p level among DN patients with different degrees of renal interstitial inflammation and renal interstitial fibrosis and tubular atrophy scores ( F = 48.73, 27.07, both P < 0.05). Correlation analysis revealed that the relative expression level of miR-24-3p in the peripheral blood of patients with DN was positively correlated with fasting blood glucose, glycated hemoglobin A1c, serum creatinine, renal interstitial inflammation score, and renal interstitial fibrosis and tubular atrophy score ( r = 0.48, 0.57, 0.63, 0.71, 0.69, all P < 0.05). It was negatively correlated with estimated glomerular filtration rate and blood magnesium level ( r = -0.72, -0.78, both P < 0.05). The relative expression level of miR-24-3p in the peripheral blood can be used to predict the occurrence of DN [area under the curve = 0.864, 95% CI: (0.813, 0.916)], and the sensitivity and specificity of this prediction were 85.0% and 79.6%, respectively. Conclusions:The expression of miR-24-3p is high in the peripheral blood of patients with DN, and its level is associated with blood glucose metabolism, blood magnesium level, renal inflammatory injury, renal interstitial fibrosis, and glomerular atrophy. Upregulation of miR-24-3p may increase the risk of renal disease and exacerbate kidney damage in patients with T2DM.

Cartilage tissue engineering offers a promising therapeutic approach for auricular, tracheal, and joint reconstruction. However, implanted engineered cartilage currently faces challenges such as host immune rejection and inflammatory reactions, which can lead to deformities and fibrosis, compromising long-term maintenance of shape and function. Effectively modulating immune and inflammatory responses is crucial for advancing the clinical application of engineered cartilage. This article reviewed relevant literature to analyze the mechanisms of inflammatory responses occurring after the implantation of tissue-engineered cartilage, and summarized the types and surface characteristics of biomaterials, providing a reference for the design of biomaterials in cartilage tissue engineering.

Cartilage tissue engineering offers a promising therapeutic approach for auricular, tracheal, and joint reconstruction. However, implanted engineered cartilage currently faces challenges such as host immune rejection and inflammatory reactions, which can lead to deformities and fibrosis, compromising long-term maintenance of shape and function. Effectively modulating immune and inflammatory responses is crucial for advancing the clinical application of engineered cartilage. This article reviewed relevant literature to analyze the mechanisms of inflammatory responses occurring after the implantation of tissue-engineered cartilage, and summarized the types and surface characteristics of biomaterials, providing a reference for the design of biomaterials in cartilage tissue engineering.

Objective:To analyze the factors affecting delayed chemotherapy in children with Burkitt lymphoma (BL) and their influence on prognosis.Methods:Retrospective cohort study. Clinical data of 591 children aged ≤18 years with BL from May 2017 to December 2022 in China Net Childhood Lymphoma (CNCL) was collected. The patients were treated according to the protocol CNCL-BL-2017. According to the clinical characteristics, therapeutic regimen was divided into group A, group B and group C .Based on whether the total chemotherapy time was delayed, patients were divided into two groups: the delayed chemotherapy group and the non-delayed chemotherapy group. Based on the total delayed time of chemotherapy, patients in group C were divided into non-delayed chemotherapy group, 1-7 days delayed group and more than 7 days delayed group. Relationships between delayed chemotherapy and gender, age, tumor lysis syndrome before chemotherapy, bone marrow involvement, disease group (B/C group), serum lactate dehydrogenase (LDH) > 4 times than normal, grade Ⅲ-Ⅳ myelosuppression after chemotherapy, minimal residual disease in the interim assessment, and severe infection (including severe pneumonia, sepsis, meningitis, chickenpox, etc.) were analyzed. Logistic analysis was used to identify the relevant factors. Kaplan-Meier method was used to analyze the patients' survival information. Log-Rank was used for comparison between groups.Results:Among 591 patients, 504 were males and 87 were females, the follow-up time was 34.8 (18.6,50.1) months. The 3-year overall survival (OS) rate was (92.5±1.1)%,and the 3-year event-free survival (EFS) rate was (90.5±1.2)%. Seventy-three (12.4%) patients were in delayed chemotherapy group and 518 (87.6%) patients were in non-delayed chemotherapy group. The reasons for chemotherapy delay included 72 cases (98.6%) of severe infection, 65 cases (89.0%) of bone marrow suppression, 35 cases (47.9%) of organ dysfunction, 22 cases (30.1%) of tumor lysis syndrome,etc. There were 7 cases of chemotherapy delay in group B, which were seen in COPADM (vincristine+cyclophosphamide+prednisone+daunorubicin+methotrexate+intrathecal injection,4 cases) and CYM (methotrexate+cytarabine+intrathecal injection,3 cases) stages. There were 66 cases of chemotherapy delay in group C, which were common in COPADM (28 cases) and CYVE 1 (low dose cytarabine+high dose cytarabine+etoposide+methotrexate, 12 cases) stages. Multinomial Logistic regression analysis showed that the age over 10 years old ( OR=0.54,95% CI 0.30-0.93), tumor lysis syndrome before chemotherapy ( OR=0.48,95% CI 0.27-0.84) and grade Ⅲ-Ⅳ myelosuppression after chemotherapy ( OR=0.55,95% CI 0.33-0.91)were independent risk factors for chemotherapy delay.The 3-year OS rate and the 3-year EFS rate of children with Burkitt lymphoma in the delayed chemotherapy group were lower than those in the non-delayed chemotherapy group ((79.4±4.9)% vs. (94.2±1.1)%, (80.2±4.8)% vs. (92.0±1.2)%,both P<0.05). The 3-year OS rate of the group C with chemotherapy delay >7 days (42 cases) was lower than that of the group with chemotherapy delay of 1-7 days (22 cases) and the non-delay group (399 cases) ((76.7±6.9)% vs. (81.8±8.2)% vs. (92.7±1.3)%, P=0.002).The 3-year OS rate of the chemotherapy delay group (9 cases) in the COP (vincristine+cyclophosphamide+prednisone) phase was lower than that of the non-chemotherapy delay group (454 cases) ((66.7±15.7)% vs. (91.3±1.4)%, P=0.005). Similarly, the 3-year OS rate of the chemotherapy delay group (11 cases) in the COPADM1 phase was lower than that of the non-chemotherapy delay group (452 cases) ((63.6±14.5)% vs. (91.5±1.3)%, P=0.001). Conclusions:The delayed chemotherapy was related to the age over 10 years old, tumor lysis syndrome before chemotherapy and grade Ⅲ-Ⅳ myelosuppression after chemotherapy in pediatric BL. There is a significant relationship between delayed chemotherapy and prognosis of BL in children.